UNSPSC 85516155: Occlusion of right foot artery with intraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of right foot artery with intraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04LV4DZ

UNSPSC 85516155 Occlusion of right foot artery with intraluminal device, percutaneous endoscopic approach (Commodity) shows little relevant recent activity under its nominal scope. The recent state and local contract opportunities tagged to this code do not involve vascular interventional procedures or the clinical services described in the code's medical-device-oriented name. Instead, the opportunities solicited under this code span occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, disability-related independent medical evaluations, surgical carve-out benefit programs, and youth detention facility healthcare services — none of which align with the specific arterial occlusion procedure the code nominally describes. This pattern suggests either a systematic coding misalignment in the state and local procurement database or that the code is rarely used for its intended commodity scope in public-sector contracting.

The five recent opportunities came from the Washington State Department of Transportation (Washington State Ferries), Collier County Board of County Commissioners (Florida), City of Phoenix Retirement Office (Arizona), City of Long Beach (California), County of Santa Clara Health System (California), and Harris County Juvenile Probation Department (Texas). The opportunities span August through October 2026, with response dates ranging from September 25 through October 16, 2026. Given the absence of actual vascular-procedure procurement under this code and the divergence between its nominal scope and what state and local bodies are actually buying under it, this Commodity code does not represent a viable business development focus for firms pursuing health-care contracting in state and local procurement.